• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊泡循环蛋白作为大脑黑质中多巴胺能神经元神经可塑性的标志物

Proteins of the Vesicular Cycle as a Marker of Neuroplasticity of Dopaminergic Neurons in the Substantia Nigra of the Brain.

作者信息

Mingazov E R, Pavlova E N, Surkov S A, Ugrumov M V

机构信息

Koltzov Institute of Developmental Biology, Russian Academy of Sciences, 119334, Moscow, Russia.

National Research University Higher School of Economics, 101000, Moscow, Russia.

出版信息

Dokl Biochem Biophys. 2019 Nov;489(1):399-402. doi: 10.1134/S1607672919060115. Epub 2020 Mar 4.

DOI:10.1134/S1607672919060115
PMID:32130610
Abstract

Nigrostriatal dopaminergic neurons (DNs), involved in the regulation of motor function, are characterized by a high plasticity. Indeed, at the death of up to 50% of DNs in Parkinson's disease, the survived neurons provide normal regulation. This study was aimed to determine whether the vesicle cycle proteins, syntaxin Ia (Syn Ia), synaptotagmin I (Syt I), Rab5a, and complexins I and II (Cmpx I and II) are involved in the mechanisms of neuroplasticity in the substantia nigra, which mainly contains cell bodies and processes of the DNs. In the neurotoxic models of Parkinson's disease in mice, it was shown that, at the degeneration of up to 50% of DNs, the content of Syt I, Syn Ia, and Cmpх I and II, involved in vesicle exocytosis, does not change in the substantia nigra as a whole but is compensatorily increased in individual survived DNs. Thus, the data obtained in this study suggest that the impairment of motor behavior, which occurs at the death of half of the nigrostriatal DNs, is not caused by the impairment of the production of vesicle cycle proteins in the survived DNs.

摘要

黑质纹状体多巴胺能神经元(DNs)参与运动功能的调节,其特点是具有高度可塑性。事实上,在帕金森病中多达50%的DNs死亡时,存活的神经元仍能提供正常调节。本研究旨在确定囊泡循环蛋白,即 syntaxin Ia(Syn Ia)、突触结合蛋白I(Syt I)、Rab5a以及复合体蛋白I和II(Cmpx I和II)是否参与黑质神经可塑性机制,黑质主要包含DNs的细胞体和突起。在小鼠帕金森病神经毒性模型中,研究表明,在多达50%的DNs发生变性时,参与囊泡胞吐作用的Syt I、Syn Ia以及Cmpx I和II的含量在整个黑质中并未改变,但在单个存活的DNs中会出现代偿性增加。因此,本研究获得的数据表明,在黑质纹状体DNs半数死亡时出现的运动行为损伤并非由存活DNs中囊泡循环蛋白产生受损所致。

相似文献

1
Proteins of the Vesicular Cycle as a Marker of Neuroplasticity of Dopaminergic Neurons in the Substantia Nigra of the Brain.囊泡循环蛋白作为大脑黑质中多巴胺能神经元神经可塑性的标志物
Dokl Biochem Biophys. 2019 Nov;489(1):399-402. doi: 10.1134/S1607672919060115. Epub 2020 Mar 4.
2
Gene expression of proteins of the vesicle cycle in dopaminergic neurons in modeling of Parkinson's disease.帕金森病模型中多巴胺能神经元囊泡循环相关蛋白的基因表达
Dokl Biochem Biophys. 2016 May;468(1):206-8. doi: 10.1134/S1607672916030133. Epub 2016 Jul 15.
3
Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.排斥导向分子a(RGMa)诱导出与帕金森病极为相似的神经病理和行为变化。
J Neurosci. 2017 Sep 27;37(39):9361-9379. doi: 10.1523/JNEUROSCI.0084-17.2017. Epub 2017 Aug 21.
4
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.线粒体 DNA 缺失在多巴胺能神经元内的积累引发神经保护机制。
Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196.
5
Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction.黑质多巴胺能神经元上生长激素释放肽受体的下调导致类似帕金森病的运动功能障碍。
Mol Brain. 2018 Feb 20;11(1):6. doi: 10.1186/s13041-018-0349-8.
6
Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.微粒体前列腺素 E 合酶-1 是帕金森病中多巴胺能神经元退行性变的关键因素。
Neurobiol Dis. 2019 Apr;124:81-92. doi: 10.1016/j.nbd.2018.11.004. Epub 2018 Nov 10.
7
Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.条件性敲除多巴胺能神经元中的 Ndufs4 可促进帕金森病样非运动症状,而不会导致多巴胺神经元丢失。
Sci Rep. 2017 Mar 22;7:44989. doi: 10.1038/srep44989.
8
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease.pRb/E2F细胞周期通路介导帕金森病中的细胞死亡。
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3585-90. doi: 10.1073/pnas.0611671104. Epub 2007 Feb 21.
9
Neuronal vulnerability in Parkinson's disease.帕金森病中的神经元易损性。
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S52-4. doi: 10.1016/S1353-8020(11)70018-9.
10
Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.秋水仙碱可保护帕金森病大鼠模型中的多巴胺能神经元。
CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):836-43. doi: 10.2174/1871527311201070836.

本文引用的文献

1
MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine.MPTP 帕金森病动物模型在转化医学中的应用
Mol Neurobiol. 2018 Apr;55(4):2991-3006. doi: 10.1007/s12035-017-0559-6. Epub 2017 Apr 29.
2
Gene expression of proteins of the vesicle cycle in dopaminergic neurons in modeling of Parkinson's disease.帕金森病模型中多巴胺能神经元囊泡循环相关蛋白的基因表达
Dokl Biochem Biophys. 2016 May;468(1):206-8. doi: 10.1134/S1607672916030133. Epub 2016 Jul 15.
3
Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
帕金森病症状前期和症状期MPTP处理小鼠黑质纹状体多巴胺能神经元中酪氨酸羟化酶的表达与活性
J Neurol Sci. 2014 May 15;340(1-2):198-207. doi: 10.1016/j.jns.2014.03.028. Epub 2014 Mar 21.
4
Neurotransmitter release: the last millisecond in the life of a synaptic vesicle.神经递质释放:突触囊泡生命的最后一刹那。
Neuron. 2013 Oct 30;80(3):675-90. doi: 10.1016/j.neuron.2013.10.022.
5
Rab4 and Rab5 GTPase are required for directional mobility of endocytic vesicles in astrocytes.Rab4 和 Rab5 GTPase 对于星形胶质细胞内吞小泡的定向迁移是必需的。
Glia. 2012 Apr;60(4):594-604. doi: 10.1002/glia.22293. Epub 2012 Jan 25.
6
Modeling of presymptomatic and symptomatic stages of parkinsonism in mice.帕金森病无症状期和有症状期的小鼠模型建立。
Neuroscience. 2011 May 5;181:175-88. doi: 10.1016/j.neuroscience.2011.03.007. Epub 2011 Mar 5.
7
Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach.实验性和人类帕金森病中的代偿机制:迈向动态研究方法
Prog Neurobiol. 1998 Jun;55(2):93-116. doi: 10.1016/s0301-0082(98)00006-9.
8
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.帕金森病的动物模型:与人类疾病现象学的实证比较。
J Neural Transm (Vienna). 1996;103(8-9):987-1041. doi: 10.1007/BF01291788.
9
The involvement of the small GTP-binding protein Rab5a in neuronal endocytosis.
Neuron. 1994 Jul;13(1):11-22. doi: 10.1016/0896-6273(94)90456-1.
10
Parkinson's disease: pathophysiology.帕金森病:病理生理学
Lancet. 1991 Jun 1;337(8753):1321-4. doi: 10.1016/0140-6736(91)92989-f.